AR044964A1 - Formulaciones para microproyecciones recubiertas que contienen contra-iones no volatiles - Google Patents
Formulaciones para microproyecciones recubiertas que contienen contra-iones no volatilesInfo
- Publication number
- AR044964A1 AR044964A1 ARP040102300A ARP040102300A AR044964A1 AR 044964 A1 AR044964 A1 AR 044964A1 AR P040102300 A ARP040102300 A AR P040102300A AR P040102300 A ARP040102300 A AR P040102300A AR 044964 A1 AR044964 A1 AR 044964A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulation
- formulations
- covered
- containing non
- microprojections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Reivindicación 1: Una composición para recubrir u dispositivo de administración transdérmica que tiene microproyecciones para perforar el estrato córneo, que comprende una formulación de un agente biológicamente activo y un contraión no volátil, teniendo dicha formulación, una vez seca, un pH más estable y mayor solubilidad. Reivindicación 33: Un dispositivo para la administración transdérmica de un agente biológicamente activo, que comprende al menos una microsaliente que perfora el estrato córneo, recubierta con una formulación, en el cual dicha formulación comprende un agente biológicamente activo y un contraión no volátil, y dicha formulación, una vez seca, tiene un pH más estable y una mayor solubilidad.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48402003P | 2003-06-30 | 2003-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR044964A1 true AR044964A1 (es) | 2005-10-12 |
Family
ID=34062010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102300A AR044964A1 (es) | 2003-06-30 | 2004-06-30 | Formulaciones para microproyecciones recubiertas que contienen contra-iones no volatiles |
Country Status (13)
Country | Link |
---|---|
US (2) | US7579013B2 (es) |
EP (1) | EP1638523B8 (es) |
JP (1) | JP5456234B2 (es) |
KR (1) | KR20060038407A (es) |
CN (1) | CN1842320B (es) |
AR (1) | AR044964A1 (es) |
AU (1) | AU2004255218A1 (es) |
BR (1) | BRPI0412029A (es) |
CA (1) | CA2530531A1 (es) |
ES (1) | ES2437565T3 (es) |
MX (1) | MXPA06000281A (es) |
TW (1) | TW200518771A (es) |
WO (1) | WO2005004842A2 (es) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6918901B1 (en) * | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
MXPA03003303A (es) * | 2000-10-13 | 2004-12-13 | Johnson & Johnson | Retenedor del miembro de microprotrusion para aplicador de impacto. |
US7419481B2 (en) * | 2000-10-13 | 2008-09-02 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
CN1250171C (zh) * | 2000-10-13 | 2006-04-12 | 阿尔扎公司 | 利用微凸起刺入皮肤的装置和方法 |
ATE428466T1 (de) * | 2000-10-26 | 2009-05-15 | Alza Corp | Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen |
WO2002074173A1 (en) * | 2001-03-16 | 2002-09-26 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
US20020193729A1 (en) * | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
ATE369802T1 (de) * | 2003-06-30 | 2007-09-15 | Alza Corp | Verfahren zum beschichten von mikrovorsprüngen zum durchstechen der haut |
CA2530531A1 (en) * | 2003-06-30 | 2005-01-20 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
US20050123507A1 (en) * | 2003-06-30 | 2005-06-09 | Mahmoud Ameri | Formulations for coated microprojections having controlled solubility |
AR044985A1 (es) * | 2003-07-02 | 2005-10-12 | Alza Corp | Metodo y parche de inmunizacion por disposicion de microproyeccion |
US20050049549A1 (en) * | 2003-08-04 | 2005-03-03 | Wong Patrick S.L. | Method and device for enhancing transdermal agent flux |
US8524272B2 (en) | 2003-08-15 | 2013-09-03 | Mylan Technologies, Inc. | Transdermal patch incorporating active agent migration barrier layer |
US8961477B2 (en) | 2003-08-25 | 2015-02-24 | 3M Innovative Properties Company | Delivery of immune response modifier compounds |
WO2005042702A2 (en) * | 2003-10-23 | 2005-05-12 | Alza Corporation | Compositions of stabilized dna for coating microprojections |
JP2007510445A (ja) * | 2003-10-24 | 2007-04-26 | アルザ・コーポレーシヨン | 経皮薬剤送達促進用の前処置法及びシステム |
BRPI0415986A (pt) * | 2003-10-28 | 2007-01-23 | Alza Corp | método e aparelho para reduzir a incidência do uso de tabaco |
JP4682144B2 (ja) | 2003-10-31 | 2011-05-11 | アルザ・コーポレーシヨン | 微小突起列のための自己−作動性アプリケーター |
EP1682012A4 (en) * | 2003-11-13 | 2008-09-24 | Alza Corp | COMPOSITION AND APPARATUS FOR TRANSDERMAL DELIVERY |
KR20070011481A (ko) * | 2004-04-13 | 2007-01-24 | 알자 코포레이션 | 다중 백신의 경피 전달용 기구 및 방법 |
AU2005244734A1 (en) * | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
CA2576852A1 (en) * | 2004-08-11 | 2006-02-23 | Alza Corporation | Apparatus and method for transdermal delivery of natriuretic peptides |
WO2006079019A2 (en) * | 2005-01-21 | 2006-07-27 | Alza Corporation | Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion |
CA2595457A1 (en) * | 2005-01-25 | 2006-08-03 | Microchips, Inc. | Control of drug release by transient modification of local microenvironments |
AU2006214236A1 (en) * | 2005-02-16 | 2006-08-24 | Alza Corporation | Apparatus and method for transdermal delivery of erythropoetin-based agents |
US20060280644A1 (en) * | 2005-06-02 | 2006-12-14 | Scott Sellers | Method for terminal sterilization of transdermal delivery devices |
JP5438872B2 (ja) * | 2005-06-02 | 2014-03-12 | アルザ コーポレイション | 経皮的送達デバイスの最終滅菌法 |
CN101267896A (zh) * | 2005-09-12 | 2008-09-17 | 阿尔扎公司 | 可涂覆的透皮给药微突起组合件 |
WO2007061964A1 (en) * | 2005-11-18 | 2007-05-31 | 3M Innovative Properties Company | Methods for coating microneedles |
WO2007064486A1 (en) * | 2005-11-30 | 2007-06-07 | 3M Innovative Properties Company | Microneedle arrays and methods of use thereof |
AU2006336187A1 (en) * | 2005-12-28 | 2007-07-26 | Alza Corporation | Stable therapeutic formulations |
AU2007225056A1 (en) * | 2006-03-15 | 2007-09-20 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia |
US20070293816A1 (en) * | 2006-04-25 | 2007-12-20 | Alza Corporation | Microprojection Array Application with Grouped Microprojections for High Drug Loading |
WO2007127815A2 (en) * | 2006-04-25 | 2007-11-08 | Alza Corporation | Microprojection array application with multilayered microprojection member for high drug loading |
US7771542B1 (en) | 2006-05-30 | 2010-08-10 | Stone Chemical Company | Compositions and methods for removing lead from metal surfaces |
CN102088991A (zh) | 2008-05-13 | 2011-06-08 | 堪萨斯大学 | 金属提取肽标签和相关方法 |
US20130053448A1 (en) | 2010-05-12 | 2013-02-28 | Louis O'Dea | Therapeutic Regimens |
EP2575845B1 (en) | 2010-05-28 | 2017-02-15 | 3M Innovative Properties Company | Aqueous formulations for coating microneedle arrays |
US9133182B2 (en) | 2010-09-28 | 2015-09-15 | Radius Health, Inc. | Selective androgen receptor modulators |
JP2013544600A (ja) * | 2010-11-23 | 2013-12-19 | プレサージュ バイオサイエンシズ,インコーポレイテッド | 固体デリバリーのための治療方法および組成物 |
CN102090904B (zh) * | 2011-02-17 | 2013-04-03 | 中国中医科学院中医临床基础医学研究所 | 中药注射剂快速过敏皮试检测仪 |
US20120222979A1 (en) | 2011-03-04 | 2012-09-06 | Elwha LLC, a limited liability company of the State of Delaware | Glassy compositions |
NL2007382C2 (en) * | 2011-09-09 | 2013-03-12 | Univ Leiden | Method to coat an active agent to a surface. |
JP2014534864A (ja) | 2011-10-28 | 2014-12-25 | プレサージュ バイオサイエンシズ,インコーポレイテッド | 薬物デリバリー方法 |
CN104080441B (zh) | 2011-11-30 | 2020-02-28 | 3M创新有限公司 | 包括肽治疗剂和氨基酸的微针装置、制备和使用其的方法 |
US9187735B2 (en) | 2012-06-01 | 2015-11-17 | University Of Kansas | Metal abstraction peptide with superoxide dismutase activity |
US10980865B2 (en) | 2012-08-10 | 2021-04-20 | Aquavit Pharmaceuticals, Inc. | Direct application system and method for the delivery of bioactive compositions and formulations |
ES2692722T3 (es) | 2013-02-13 | 2018-12-04 | Hisamitsu Pharmaceutical Co., Inc. | Composición de recubrimiento de microagujas y dispositivo de microagujas |
WO2014126105A1 (ja) | 2013-02-13 | 2014-08-21 | 久光製薬株式会社 | マイクロニードルコーティング用組成物及びマイクロニードルデバイス |
US9782344B2 (en) * | 2013-08-22 | 2017-10-10 | Zp Opco, Inc. | Stable glucagon peptide formulations |
US9173924B2 (en) * | 2013-08-22 | 2015-11-03 | Zp Opco, Inc. | Stable glucagon peptide formulations |
EP3250228A1 (en) | 2015-01-27 | 2017-12-06 | 3M Innovative Properties Company | Alum-containing coating formulations for microneedle vaccine patches |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9375478B1 (en) | 2015-01-30 | 2016-06-28 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
EP4039253A1 (en) | 2015-04-29 | 2022-08-10 | Radius Pharmaceuticals, Inc. | Methods of treating cancer |
JP7116680B2 (ja) | 2015-10-09 | 2022-08-10 | キンデーバ ドラッグ デリバリー リミティド パートナーシップ | コーティングされたマイクロニードルアレイのための亜鉛組成物 |
WO2017143345A1 (en) | 2016-02-19 | 2017-08-24 | Zp Opco, Inc. | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines |
EP3998061A1 (en) * | 2016-04-18 | 2022-05-18 | Radius Health, Inc. | Formulations of abaloparatide, transdermal patches thereof, and uses thereof |
WO2017223115A1 (en) | 2016-06-22 | 2017-12-28 | Radius Health, Inc. | Ar+ breast cancer treatment methods |
AR109621A1 (es) * | 2016-10-24 | 2018-12-26 | Janssen Pharmaceuticals Inc | Formulaciones de vacunas contra glucoconjugados de expec |
EP3565542B1 (en) | 2017-01-05 | 2024-04-10 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
US11660264B2 (en) | 2017-08-23 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
SG10201800072YA (en) * | 2018-01-03 | 2019-08-27 | Micropoint Tech Pte Ltd | Microneedle Patches Comprising Corticosteroid |
US11660265B2 (en) | 2018-06-28 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
CN108721598B (zh) * | 2018-07-03 | 2020-06-05 | 北京市新里程医药科技有限公司 | 一种缩宫素原料的制备方法及其药物组合物和制剂 |
JP7473486B2 (ja) | 2018-07-04 | 2024-04-23 | ラジウス ファーマシューティカルズ,インコーポレイテッド | Rad1901-2hclの多形形態 |
Family Cites Families (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123212A (en) | 1964-03-03 | Multiple disposable intracutaneous injector package | ||
USRE25637E (en) | 1964-09-08 | Means for vaccinating | ||
GB179994A (en) | 1921-02-02 | 1922-05-02 | Achilee Macchioni | Throttling of the exhaust in a two-stroke cycle internal combustion motor applied to a locomotive for the purpose of increasing the power of the said motor |
US2619962A (en) | 1948-02-19 | 1952-12-02 | Res Foundation | Vaccination appliance |
US2893392A (en) | 1958-01-08 | 1959-07-07 | American Cyanamid Co | Article of manufacture for intracutaneous injections |
US3072122A (en) | 1959-01-15 | 1963-01-08 | Rosenthal Sol Roy | Package for transcutaneous injection |
US3136314A (en) | 1960-08-01 | 1964-06-09 | Kravitz Harvey | Vaccinating devices |
US3221739A (en) | 1962-03-26 | 1965-12-07 | Rosenthal Sol Roy | Injection device |
US3221740A (en) | 1962-08-31 | 1965-12-07 | Rosenthal Sol Roy | Injection device |
US3964482A (en) | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
US3678150A (en) | 1971-07-27 | 1972-07-18 | American Cyanamid Co | Process for improving the stability of ppd, qt and histoplasmin on tine applicators |
BE795384A (fr) | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
OA05448A (fr) | 1975-10-16 | 1981-03-31 | Manufrance Manufacture Francai | Dispositif vaccinateur multipénétrant. |
FR2474856A1 (fr) | 1980-01-31 | 1981-08-07 | Merieux Inst | Dispositif scarificateur |
SE8501990D0 (sv) | 1985-04-24 | 1985-04-24 | Pharmacia Ab | Beleggningsforfarande |
KR970008118B1 (ko) | 1987-07-09 | 1997-05-21 | 엘테에스 로오만 테라피-지스테메 게엠베하 운트 콤파니 카게 | 피부 침투성 치료 시스템 |
US5051132A (en) * | 1989-06-15 | 1991-09-24 | Nippon Kayaku Kabushiki Kaisha | Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin |
CA2016900A1 (en) | 1989-07-06 | 1991-01-06 | Ronald J. Filipski | Tines structure in clinical applicator |
EP0429842B1 (en) | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
JPH04134033A (ja) * | 1990-01-19 | 1992-05-07 | Nippon Kayaku Co Ltd | エトポシド−2−ジメチルアミノ体の凍結乾燥製剤 |
US5279544A (en) | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
DE4242919A1 (de) * | 1992-12-18 | 1994-06-23 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF |
DE4341444C2 (de) | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
US5487726A (en) | 1994-06-16 | 1996-01-30 | Ryder International Corporation | Vaccine applicator system |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
PL184068B1 (pl) | 1994-08-04 | 2002-08-30 | Quadrant Holdings Cambridge | Kompozycja farmaceutyczna o wysokiej stabilności i sposób wytwarzania kompozycji farmaceutycznej o wysokiej stabilności |
EP0782614A1 (en) | 1994-09-30 | 1997-07-09 | Rutgers, The State University Of New Jersey | Direct introduction of foreign materials into cells |
DE59505328D1 (de) | 1994-12-09 | 1999-04-15 | Novartis Ag | Transdermales system |
US5866536A (en) * | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1996037256A1 (en) | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical patch for enhancing the delivery of compounds through the skin |
AU5740496A (en) | 1995-05-22 | 1996-12-11 | General Hospital Corporation, The | Micromechanical device and method for enhancing delivery of compounds through the skin |
DE19525607A1 (de) | 1995-07-14 | 1997-01-16 | Boehringer Ingelheim Kg | Transcorneales Arzneimittelfreigabesystem |
US6230051B1 (en) | 1996-06-18 | 2001-05-08 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
DE69722414T2 (de) | 1996-07-03 | 2004-05-19 | Altea Therapeutics Corp. | Mehrfache mechanische mikroperforierung von haut oder schleimhäuten |
US5916524A (en) | 1997-07-23 | 1999-06-29 | Bio-Dot, Inc. | Dispensing apparatus having improved dynamic range |
US5738728A (en) | 1996-07-26 | 1998-04-14 | Bio Dot, Inc. | Precision metered aerosol dispensing apparatus |
US5743960A (en) | 1996-07-26 | 1998-04-28 | Bio-Dot, Inc. | Precision metered solenoid valve dispenser |
US5741554A (en) | 1996-07-26 | 1998-04-21 | Bio Dot, Inc. | Method of dispensing a liquid reagent |
US5983136A (en) | 1996-09-17 | 1999-11-09 | Deka Products Limited Partnership | System for delivery of drugs by transport |
CN1133472C (zh) | 1996-12-20 | 2004-01-07 | 阿尔萨公司 | 增加经皮样剂流量的装置 |
DE19654391A1 (de) | 1996-12-27 | 1998-07-02 | Basf Ag | Katalysator zur selektiven Herstellung von Propylen aus Propan |
BR9714113A (pt) | 1996-12-31 | 2000-03-21 | Shell Int Research | Plataforma de tirante |
US6918901B1 (en) | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
DK1037686T3 (da) | 1997-12-11 | 2006-01-02 | Alza Corp | Apparat til forögelse af transdermal gennemströmning af midler |
ATE221400T1 (de) | 1997-12-11 | 2002-08-15 | Alza Corp | Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses |
JP2001525227A (ja) | 1997-12-11 | 2001-12-11 | アルザ・コーポレーション | 経皮的薬剤流量を高めるための装置 |
PT1051155E (pt) | 1998-01-30 | 2002-10-31 | Novartis Consumer Health Sa | Solucoes nasais |
US6091975A (en) | 1998-04-01 | 2000-07-18 | Alza Corporation | Minimally invasive detecting device |
WO1999064580A1 (en) | 1998-06-10 | 1999-12-16 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
EP1109594B1 (en) | 1998-08-31 | 2004-10-27 | Johnson & Johnson Consumer Companies, Inc. | Electrotransport device comprising blades |
JP3722268B2 (ja) * | 1998-09-03 | 2005-11-30 | 栗田工業株式会社 | 抗菌性組成物 |
SE9803517D0 (sv) * | 1998-10-15 | 1998-10-15 | Astra Ab | Pharmaceutical preparation |
AR022119A1 (es) * | 1998-12-22 | 2002-09-04 | Bausch & Lomb | Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas |
GB9901253D0 (en) * | 1999-01-20 | 1999-03-10 | Isis Innovation | Bis-terpyridine-platinum(II) complexes |
US6884427B1 (en) | 1999-02-08 | 2005-04-26 | Aderans Research Institute, Inc. | Filamentary means for introducing agents into tissue of a living host |
US6743211B1 (en) | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
US6379324B1 (en) | 1999-06-09 | 2002-04-30 | The Procter & Gamble Company | Intracutaneous microneedle array apparatus |
US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
GB9916316D0 (en) * | 1999-07-12 | 1999-09-15 | Quadrant Holdings Cambridge | Dry powder compositions |
US6623457B1 (en) | 1999-09-22 | 2003-09-23 | Becton, Dickinson And Company | Method and apparatus for the transdermal administration of a substance |
US6835184B1 (en) | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
US20020095134A1 (en) | 1999-10-14 | 2002-07-18 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
EP1239916B1 (en) * | 1999-12-10 | 2005-11-23 | ALZA Corporation | Device and method for enhancing microprotrusion skin piercing |
CA2334746A1 (en) * | 2000-02-09 | 2001-08-09 | Sumitomo Chemical Co., Ltd. | Process for producing optically active hemiesters |
CA2380423A1 (en) * | 2000-05-17 | 2001-11-22 | Bionebraska, Inc. | Peptide pharmaceutical formulations |
ES2295161T3 (es) * | 2000-05-17 | 2008-04-16 | Senju Pharmaceutical Co., Ltd. | Solucion oftalmica. |
US6565532B1 (en) | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
US6537242B1 (en) | 2000-06-06 | 2003-03-25 | Becton, Dickinson And Company | Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance |
US6589202B1 (en) | 2000-06-29 | 2003-07-08 | Becton Dickinson And Company | Method and apparatus for transdermally sampling or administering a substance to a patient |
GB0016002D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
US20050008683A1 (en) | 2000-06-29 | 2005-01-13 | Becton Dickinson And Company | Method for delivering interferons to the intradermal compartment |
US6440096B1 (en) | 2000-07-14 | 2002-08-27 | Becton, Dickinson And Co. | Microdevice and method of manufacturing a microdevice |
GB0017999D0 (en) * | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
NZ524646A (en) * | 2000-09-08 | 2004-10-29 | Alza Corp | Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
MXPA03003303A (es) | 2000-10-13 | 2004-12-13 | Johnson & Johnson | Retenedor del miembro de microprotrusion para aplicador de impacto. |
JP4198985B2 (ja) | 2000-10-13 | 2008-12-17 | アルザ・コーポレーシヨン | マイクロブレードアレー衝撃アプリケータ。 |
CN1250171C (zh) | 2000-10-13 | 2006-04-12 | 阿尔扎公司 | 利用微凸起刺入皮肤的装置和方法 |
ATE428466T1 (de) * | 2000-10-26 | 2009-05-15 | Alza Corp | Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen |
US9302903B2 (en) | 2000-12-14 | 2016-04-05 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
WO2002074173A1 (en) | 2001-03-16 | 2002-09-26 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
US20020193729A1 (en) | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
MXPA03009603A (es) * | 2001-04-20 | 2004-12-06 | Johnson & Johnson | Arreglo de microproyeccion que tiene un agente benefico que contiene un recubrimiento. |
US6881203B2 (en) | 2001-09-05 | 2005-04-19 | 3M Innovative Properties Company | Microneedle arrays and methods of manufacturing the same |
WO2003026733A2 (en) | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Microneedle with membrane |
US6689100B2 (en) | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
JP2005511248A (ja) * | 2001-10-29 | 2005-04-28 | ベクトン・ディキンソン・アンド・カンパニー | 物質を送達するための方法およびデバイス |
EP1485317A2 (en) | 2001-11-30 | 2004-12-15 | Alza Corporation | Methods and apparatuses for forming microprojection arrays |
DE60223844T2 (de) | 2001-12-20 | 2008-08-28 | Alza Corp., Mountain View | Mikrovorsprünge zum durchstechen der haut mit stechtiefensteuerung |
US7015262B2 (en) | 2002-05-01 | 2006-03-21 | Lifescan, Inc. | Hydrophilic coatings for medical implements |
JP2006500974A (ja) | 2002-06-28 | 2006-01-12 | アルザ・コーポレーシヨン | 被覆され微細突起物を有する経皮的薬物送達装置 |
AR042815A1 (es) * | 2002-12-26 | 2005-07-06 | Alza Corp | Dispositivo de suministro de agente activo que tiene miembros compuestos |
CA2530531A1 (en) * | 2003-06-30 | 2005-01-20 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
ATE369802T1 (de) * | 2003-06-30 | 2007-09-15 | Alza Corp | Verfahren zum beschichten von mikrovorsprüngen zum durchstechen der haut |
US20050123507A1 (en) | 2003-06-30 | 2005-06-09 | Mahmoud Ameri | Formulations for coated microprojections having controlled solubility |
AR044985A1 (es) * | 2003-07-02 | 2005-10-12 | Alza Corp | Metodo y parche de inmunizacion por disposicion de microproyeccion |
JP4682144B2 (ja) | 2003-10-31 | 2011-05-11 | アルザ・コーポレーシヨン | 微小突起列のための自己−作動性アプリケーター |
EP1682012A4 (en) | 2003-11-13 | 2008-09-24 | Alza Corp | COMPOSITION AND APPARATUS FOR TRANSDERMAL DELIVERY |
WO2006079019A2 (en) * | 2005-01-21 | 2006-07-27 | Alza Corporation | Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion |
US9960402B2 (en) | 2016-09-07 | 2018-05-01 | Thunder Power New Energy Vehicle Development Company Limited | Process of manufacturing a battery system assembly using the battery system assembly press |
-
2004
- 2004-06-29 CA CA002530531A patent/CA2530531A1/en not_active Abandoned
- 2004-06-29 KR KR1020057025323A patent/KR20060038407A/ko not_active Application Discontinuation
- 2004-06-29 EP EP04756422.4A patent/EP1638523B8/en active Active
- 2004-06-29 TW TW093119156A patent/TW200518771A/zh unknown
- 2004-06-29 MX MXPA06000281A patent/MXPA06000281A/es unknown
- 2004-06-29 CN CN2004800243347A patent/CN1842320B/zh not_active Expired - Fee Related
- 2004-06-29 JP JP2006518731A patent/JP5456234B2/ja not_active Expired - Fee Related
- 2004-06-29 US US10/880,702 patent/US7579013B2/en active Active
- 2004-06-29 BR BRPI0412029-9A patent/BRPI0412029A/pt not_active IP Right Cessation
- 2004-06-29 ES ES04756422.4T patent/ES2437565T3/es active Active
- 2004-06-29 WO PCT/US2004/021004 patent/WO2005004842A2/en active Application Filing
- 2004-06-29 AU AU2004255218A patent/AU2004255218A1/en not_active Abandoned
- 2004-06-30 AR ARP040102300A patent/AR044964A1/es not_active Application Discontinuation
-
2009
- 2009-08-24 US US12/583,761 patent/US8920817B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20100221305A1 (en) | 2010-09-02 |
US20040265354A1 (en) | 2004-12-30 |
US8920817B2 (en) | 2014-12-30 |
EP1638523B1 (en) | 2013-10-30 |
JP2007527392A (ja) | 2007-09-27 |
JP5456234B2 (ja) | 2014-03-26 |
EP1638523B8 (en) | 2013-12-25 |
CN1842320B (zh) | 2013-06-19 |
ES2437565T3 (es) | 2014-01-13 |
CN1842320A (zh) | 2006-10-04 |
TW200518771A (en) | 2005-06-16 |
WO2005004842A2 (en) | 2005-01-20 |
CA2530531A1 (en) | 2005-01-20 |
MXPA06000281A (es) | 2006-07-03 |
KR20060038407A (ko) | 2006-05-03 |
EP1638523A2 (en) | 2006-03-29 |
AU2004255218A1 (en) | 2005-01-20 |
WO2005004842A3 (en) | 2005-04-21 |
US7579013B2 (en) | 2009-08-25 |
BRPI0412029A (pt) | 2006-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR044964A1 (es) | Formulaciones para microproyecciones recubiertas que contienen contra-iones no volatiles | |
AR046824A1 (es) | Composicion y aparato para la administracion transdermica. | |
AR054227A1 (es) | Composicion de principios activos | |
TW200618830A (en) | Micorprojection apparatus and system with low infection potential | |
CY1120462T1 (el) | Τοπικες ανθελμινθικες κτηνιατρικες τυποποιησεις | |
CY1118182T1 (el) | Σκευασματα ελεγχομενης αποδεσμευσης | |
BRPI0412975A (pt) | espuma penetrante para uso farmacêutico | |
CL2003002277A1 (es) | Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente. | |
AR055838A1 (es) | Formulaciones para microproyecciones recubiertas que tienen solubilidad controlada | |
WO2006009987A3 (en) | Dissolvable film composition | |
SV2006002165A (es) | Regimenes y kits de progestina ciclica ref. am101677 | |
AR056926A1 (es) | Microproyecciones recubiertas que tienen variabilidad reducida y método para producir las mismas | |
AR047112A1 (es) | Composiciones de adn estabilizado para recubrir microproyecciones | |
AR027091A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
WO2008011625A3 (en) | Microneedle devices and methods of drug delivery or fluid withdrawal | |
MX2007002189A (es) | Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos. | |
AR046608A1 (es) | Aparato para la administracion transdermica de agentes a base de nicotina | |
AR042815A1 (es) | Dispositivo de suministro de agente activo que tiene miembros compuestos | |
AR047229A1 (es) | Administracion de conjugados polimericos de peptidos y proteinas terapeuticos por medio de microproyecciones revestidas | |
ES2181659T3 (es) | Aparato de entrega de "cebo y engaño" para insectos. | |
DE60005819D1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
DE602005011105D1 (de) | Implantierbare arzneiabgabevorrichtung mit drahtfäden | |
BRPI0416613A (pt) | composição e forma de dosagem compreendendo uma molécula anfifìlica como um veìculo de suspensão | |
WO2004000389A3 (en) | Rapidly dissolving micro-perforator for drug delivery and other applications | |
SE0004671D0 (sv) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |